The FDA on Thursday approved label changes for six hormone replacement therapies (HRTs) that remove boxed warnings for cardiovascular disease, breast cancer, and probable dementia. For more than two ...

Timi is a news and deals writer who's been reporting on technology for over a decade. He loves breaking down complex subjects into easy-to-read pieces that keep you informed. But his recent passion ...

The FDA has updated the safety labeling for axicabtagene ciloleucel (Yescarta, Kite Oncology) ­— a CAR T-cell therapy — extending its indication to include patients with relapsed or refractory primary ...

BOSTON — Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous ...

(RTTNews) - Kite, a Gilead Company (GILD), announced the FDA approved an update to the Yescarta prescribing information removing the previous Limitations of Use in patients with relapsed or refractory ...

The U.S. Food and Drug Administration (FDA) has updated the warning label for the Depo-Provera birth control shot to include information about the risk of meningioma brain tumors. The label update is ...

Regulator asks drugmakers to remove warnings of suicidal thoughts from GLP-1 drugs' labels FDA finds no link between GLP-1 drugs and suicidal thoughts Novo Nordisk and Eli Lilly welcome FDA's ...

(RTTNews) - Akeso, Inc. (AKESF, 9926.HK) announced that China's National Medical Products Administration has approved a significant label update for its first-in-class PD-1/VEGF bispecific antibody, ...

A nationwide movement to warn consumers about the health risks of cooking with natural gas has hit a speed bump in Colorado. On Dec. 19, a federal court issued an injunction against the state, ...

The label revision follows emerging evidence linking long-term use of Depo-Provera (medroxyprogesterone acetate) to a higher likelihood of developing meningiomas — tumors that, while often benign, can ...

FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC) ...

Microsoft released Azure Cosmos DB Python SDK version 4.14.0, a stable update designed to support advanced AI workloads and enhance performance for data-driven applications. The release includes new ...